|
Cardiac - Anesthesia:
|
|
Effect of lung ventilation with 50% oxygen in air or nitrous oxide versus 100% oxygen on oxygenation index after cardiopulmonary bypass.
Sinha PK, Neema PK, Unnikrishnan KP, Varma PK, Jaykumar K, Rathod RC.
J Cardiothorac Vasc Anesth 2006;20:136-42.
|
|
Cardiac - Diagnostic:
|
|
Meta-analysis of comparative diagnostic performance of magnetic resonance imaging and multislice computed tomography for noninvasive coronary angiography.
Schuijf JD, Bax JJ, Shaw LJ, et al.
Am Heart J 2006;51:404-11.
|
|
Cardiac - Monitoring/Transfusion:
|
|
Transfusion increases the risk of postoperative infection after cardiovascular surgery.
Banbury MK, Brizzio ME, Rajeswaran J, Lytle BW, Blackstone EH.
J Am Coll Surg 2006;202:131–38.
A double-blind, placebo-controlled trial of epsilon-aminocaproic acid for reducing blood loss in coronary artery bypass grafting surgery.
Kikura M, Levy JH, Tanaka KA, Ramsay JG.
J Am Coll Surg 2006;202:216–22.
|
|
Cardiac - Pharmacology:
|
Back to the top
|
|
The risk associated with aprotinin in cardiac surgery.
Mangano DT, Tudor IC, Dietzel C
N Engl J Med 2006;354:353-65.
Effect of aprotinin on postoperative blood loss in off-pump coronary artery bypass surgery.
Durand M, Chavanon O, Tessier Y, et al.
J Card Surg 2006;21:17-21.
Effect of atorvastatin on circulating proinflammatory T-lymphocyte subsets and soluble CD40 ligand in patients with stable coronary artery disease—A randomized, placebo-controlled study
Alber HF, Frick M, Suessenbacher A, et al.
Am Heart J 2006;151:139.e1-139.e7.
Aspirin and clopidogrel resistance: an emerging clinical entity.
Wang TH, Bhatt DL, Topol EJ.
Eur Heart J 2006;27:647-654.
|
|
Congenital:
|
Back to the top
|
|
Fetal aortic valve stenosis and the evolution of hypoplastic left heart syndrome: patient selection for fetal intervention.
Mäkikallio K, McElhinney DB, Levine JC, et al.
Circulation 2006;113:1401-05.
|
|
Coronary Disease:
|
Back to the top
|
|
Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease.
Lee MS, Kapoor N, Jamal F, et al.
J Am Coll Cardiol 2006;47:864-70.
Sirolimus-eluting versus paclitaxel-eluting stent Implantation for the percutaneous treatment of left main coronary artery disease: a combined RESEARCH and T-SEARCH long-term analysis.
Valgimigli M, Malagutti P, Aoki J, et al.
J Am Coll Cardiol 2006;47:507–14.
Predictors of revascularization method and long-term outcome of percutaneous coronary intervention or repeat coronary bypass surgery in patients with multivessel coronary disease and previous coronary bypass surgery.
Brener SJ, Lytle BW, Casserly IP, Ellis SG, Topol EJ, Lauer MS.
Eur Heart J 2006;27:413-418.
Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the society of thoracic surgeons national adult cardiac database.
Cooper WA, O’Brien SM, Thourani VH, et al
Circulation 2006;113:1063-70.
|
|
Electrophysiology - Arrhythmias:
|
Back to the top
|
|
Catheter ablation of permanent atrial fibrillation: medium term results.
Earley MJ, Abrams DJR, Staniforth AD, Sporton SC, Schilling RJ.
Heart 2006;92:233-238.
Prediction of atrial fibrillation after coronary artery bypass grafting: the role of chemoreflexsensitivity and P wave signal averaged ECG.
Budeusa M, Hennersdorf M, Rholen S, et al.
Intl J Cardiol 2006;106:67– 74.
|
|
Endovascular Therapy:
|
Back to the top
|
|
Transcatheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: results of the U.S. phase I trial.
Fu YC, Bass J, Amin Z, et al.
J Am Coll Cardiol 2006;47:319-25.
Endograft exclusion of acute and chronic descending thoracic aortic dissections.
Song TK, Donayre CE, Walot I, et al.
J Vasc Surg 2006;43:247-58.
Endovascular stent-graft treatment of penetrating aortic ulcer.
Eggebrecht H, Herold U, Schmermund A, et al.
Am Heart J 2006;151:530-6.
Endovascular stent–graft placement in aortic dissection: a meta-analysis.
Eggebrecht H, Nienaber CA, Neuhäuser M, et al.
Eur Heart J 2006;27:489-98.
|
|
Great Vessels:
|
Back to the top
|
|
Aortic arch reconstruction: safety of moderate hypothermia and antegrade cerebral perfusion during systemic circulatory arrest.
Cook RC, Gao M, Macnab AJ, Fedoruk LM, Day N, Janusz MT.
J Card Surg 2006;21:158-64.
Clinical predictors for prolonged intensive care unit stay in adults undergoing thoracic aortic surgery requiring deep hypothermic circulatory arrest.
Augoustides JG, Pochettino A, Ochroch EA, et al.
J Cardiothorac Vasc Anesth 2006;20:3-7.
Thirty-day mortality statistics underestimate the risk of repair of thoracoabdominal aortic aneurysms: a statewide experience.
Rigberg DA, McGory ML, Zingmond DS, et al.
J Vasc Surg 2006;43:217-22.
|
|
Heart Failure - Congestive/Ischemic:
|
Back to the top
|
|
Renal function as a predictor of outcome in a broad spectrum of patients with heart failure.
Hillege HL, Nitsch D, Pfeffer MA, et al.
Circulation 2006;113:671-78.
|
|
Mechanical Circulatory Support:
|
Back to the top
|
|
Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure
Dang NC, Topkara VK, Mercando M, et al.
J Heart Lung Transplant 2006;25:1– 6.
Effect of mechanical circulatory support on outcomes after heart transplantation.
Drakos SG, Kfoury AG, Long JW, et al.
J Heart Lung Transplant 2006;25:22– 8.
|
|
Molecular Biology:
|
Back to the top
|
|
Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial.
Janssens S, Dubois C, Bogaert J, et al>
Lancet 2006;367:113–21.
|
|
Myocardial Infarction:
|
Back to the top
|
|
Emergency revascularization in patients with cardiogenic shock on admission: a report from the SHOCK trial and registry.
Jeger RV, Harkness SM, Ramanathan K, et al.
Eur Heart J 2006;27:664-670.
|
|
Peripheral Vascular:
|
Back to the top
|
|
Extracardiac vascular disease and effectiveness of sustained clopidogrel treatment.
Mukherjee D, Topol EJ, Moliterno DJ, et al.
Heart 2006;92:49-51.
|
|
Quality/Outcomes:
|
Back to the top
|
|
Risk Stratification of In-Hospital Mortality for Coronary Artery Bypass Graft Surgery.
Hannan EL, Wu C, Bennett EV, et al.
J Am Coll Cardiol 2006;47:661-8.
Subgroup analyses in therapeutic cardiovascular clinical trials: Are most of them misleading?
Hernández AV, Boersma E, Murray GD, Habbema JDF, Steyerberg EW
Am Heart J 2006;151:257-64.
Renal function and outcome from coronary artery bypass grafting: impact on mortality after a 2.3-year follow-up.
Hillis GS, Croal BL, Buchan KG, et al.
Circulation 2006;113:1056-62.
|
|
Randomized Controlled Trials:
|
Back to the top
|
|
Quality of reporting of noninferiority and equivalence randomized trials.
Henanff AL, Giraudeau B, Baron G, Ravaud P.
JAMA 2006;295:1147-51.
Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: a multicenter, randomized, double-blind trial.
Schmermund A, Achenbach S, Budde T, et al.
Circulation 2006;113:427-37.
|
|
Transplantation - Heart:
|
Back to the top
|
|
Pretransplant diabetes, not donor age, predicts long-term outcomes in cardiac transplantation.
Meyer SR, Modry DL, Norris CM, et al.
J Card Surg 2006;21:117-21.
Percutaneous coronary interventions with stents in cardiac transplant recipients.
Bader FM, Kfoury AG, Gilbert EM, et al.
J Heart Lung Transplant 2006;25:298–301.
Switch from calcineurin inhibitors to sirolimus-induced renal recovery in heart transplant recipients in the midterm follow-up.
Bestetti R, Theodoropoulos TAD, Burdmann EA, Filho MA, Cordeiro JA, Villafanha D.
Transplantation 2006;81:692-96
|
|
Valve Disease:
|
Back to the top
|
|
Treatment of calcific aortic stenosis with the percutaneous heart valve mid-term follow-up from the initial feasibility studies: the French experience.
Cribier A, Eltchaninoff H, Tron C, et al.
J Am Coll Cardiol 2006;47:1214 –23.
In vivo testing of an infection-resistant annuloplasty ring.
Monahan TS, Phaneuf MD, Contreras MA, et al.
J Surg Res 2006;130:140–45.
Percutaneous aortic valve implantation retrograde from the femoral artery.
Webb JG, Chandavimol M, Thompson CR, et al.
Circulation 2006;113:842-50.
Percutaneous transvenous mitral annuloplasty: initial human experience with device implantation in the coronary sinus.
Webb JG, Harnek J, Munt BI, et al
Circulation 2006;113:851-55.
Impact of prosthesis-patient mismatch on cardiac events and midterm mortality after aortic valve replacement in patients with pure aortic stenosis.
Tasca G, Mhagna Z, Perotti S, et al.
Circulation 2006;113:570-76.
Impact of prosthesis-patient mismatch on long-term survival in patients with small St. Jude medical mechanical prostheses in the aortic position.
Mohty-Echahidi D, Malouf JF, Girard SE, et al.
Circulation 2006;113:420-26.
|
|
Vascular:
|
Back to the top
|
|
|
Print
E-Mail
Facebook
Twitter
Sharethis